Ongoing mycophenolate treatment impairs anti-sars-cov-2 vaccination response in patients affected by chronic inflammatory autoimmune diseases or liver transplantation recipients: results of the rivalsa prospective cohort

HIGHLIGHTS

• who: Erika Zecca and collaborators from the Department of Translational Medicine, Università del Piemonte Orientale (UPO), Novara, ItalyUnits of "Maggiore della Carità" University Hospital in Novara: of those, were healthy subjects have published the paper: Ongoing Mycophenolate Treatment Impairs Anti-SARS-CoV-2 Vaccination Response in Patients Affected by Chronic Inflammatory Autoimmune Diseases or Liver Transplantation Recipients: Results of the RIVALSA Prospective Cohort, in the Journal: (JOURNAL)
• what: Such data thus raise the question about the effectiveness of anti-SARS-CoV-2 vaccination in DMARD-treated patients and foster new studies aimed to evaluate immunomodulatory . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.